Pure Biologics Spólka Akcyjna reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was PLN 25.6 million compared to PLN 11.77 million a year ago. Basic loss per share from continuing operations was PLN 11.53 compared to PLN 5.3 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.41 PLN | +1.51% | +0.14% | -41.38% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-41.38% | 6.12M | |
+29.03% | 48.16B | |
-0.10% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+11.48% | 25.59B | |
-22.74% | 18.96B | |
+9.06% | 12.92B | |
+30.01% | 12.03B | |
-1.51% | 11.77B |
- Stock Market
- Equities
- PUR Stock
- News Pure Biologics S.A.
- Pure Biologics Spólka Akcyjna Reports Earnings Results for the Full Year Ended December 31, 2022